Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
834 0 |
SM ISO690:2012 BEJAGAM, Shabari Nath, FONARI, Marina, AVERKIEV, Boris B., KHRUSTALEV, Victor N., LINDLINE, Jennifer, TIMOFEEVA, Tatiana. Adducts of N-Heterocyclic Drugs, Niacin, Allopurinol, and Amiloride, with 2,4-Pyridinedicarboxylic Acid Coformer. In: Crystal Growth and Design, 2017, nr. 8(17), pp. 4237-4245. ISSN 1528-7483. DOI: https://doi.org/10.1021/acs.cgd.7b00542 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Crystal Growth and Design | ||||||
Numărul 8(17) / 2017 / ISSN 1528-7483 | ||||||
|
||||||
DOI:https://doi.org/10.1021/acs.cgd.7b00542 | ||||||
Pag. 4237-4245 | ||||||
|
||||||
Vezi articolul | ||||||
Rezumat | ||||||
A co-crystallization of three drug molecules, niacin (3-pyridine-carboxylic acid = NIA), allopurinol (pyrazolo(3,4-d)pyrimidin-4-one = ALP), and amiloride (3,5-diamino-6-chloro-pyrazine-2-carbonyl)-guanidine = AMI), with the same coformer, 2,4-pyridinedicarboxylic acid (PDA), resulted in three new crystalline products, (NIA)(PDA) (1), (ALP)2(PDA)·1.5H2O (2), and (AMI)2(PDA)2(H2O)2 (3). The formation of new phases was confirmed by IR spectra and X-ray single-crystal and powder diffraction analysis. The proton transfer resulted in the zwitterionic co-crystal 1. In co-crystal 2, neutral ALP molecules existed in the oxo-tautomeric form. Compound 3 crystallizes as the salt with the guanidinium cationic part as in the started amiloride hydrochloride hydrate, and the PDA coformer as the zwitterionic pyridinium dicarboxylate anion. Thus, the diversity of the PDA coformer ionization states included the neutral, zwitterion, and zwitterion anionic forms. All compounds were layered structures where the heterocyclic molecules were linked in the H-bonded corrugated layers stabilized by the diverse conventional and charge-assisted hydrogen bonds with π-π stacking interactions between the layers supported by the mediated water molecules in 2 and 3. |
||||||
Cuvinte-cheie Carboxylation, carboxylic acids, Hydrogen bonds, Organic compounds, Pyridine, single crystals, Drug products |
||||||
|
Google Scholar Export
<meta name="citation_title" content="Adducts of N-Heterocyclic Drugs, Niacin, Allopurinol, and Amiloride, with 2,4-Pyridinedicarboxylic Acid Coformer"> <meta name="citation_author" content="Bejagam Shabari Nath"> <meta name="citation_author" content="Fonari Marina"> <meta name="citation_author" content="Averkiev Boris B."> <meta name="citation_author" content="Khrustalev Victor N."> <meta name="citation_author" content="Lindline Jennifer"> <meta name="citation_author" content="Timofeeva Tatiana"> <meta name="citation_publication_date" content="2017/08/02"> <meta name="citation_journal_title" content="Crystal Growth and Design"> <meta name="citation_volume" content="17"> <meta name="citation_issue" content="8"> <meta name="citation_firstpage" content="4237"> <meta name="citation_lastpage" content="4245"> <meta name="citation_pdf_url" content="https://pubs.acs.org/doi/10.1021/acs.cgd.7b00542">